September 16, 2021
One in eight women in the United States will be diagnosed with invasive breast cancer in her lifetime, according to the American Cancer Society. You play an integral role in early detection by recommending regular screenings to your patients. Early detection
through regular screening is key to a better outcome for your patients.
The Breast Cancer Screening (BCS) HEDIS® star measure assesses female patients ages 50–74 who had a mammogram to screen for breast cancer in the past two years.
The BCS tip sheet has information about this measure, including information to include in medical records, codes to include on patient claims to exclude for mastectomy and tips for talking with patients.
The Advanced Illness and Frailty
Exclusions Guide also has additional measure guidance.
The National Committee for Quality Assurance (NCQA) allows patients to be excluded from the measure due to advanced illness and frailty. They acknowledge that mammography most likely would not benefit patients who are in declining health.
For more information and/or questions regarding this article,
email Premera’s Provider Clinical Consultant team.
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).